The UltraSEEK® Melanoma Panel enables study of disease progression and resistance in melanomas. Detects more than 55 clinically relevant variants across 13 genes including BRAF, KIT and NRAS. Identifes variants at as low as 0.1% variant allele frequency.
Uses as little as 10 ng of cfDNA. 1 hour of hands-on time and 8 hours of total time.